Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
Emergent BioSolutions announced a $54 million contract award with the U.S. government and $6.6 million in new orders from an international government partner to supply smallpox medical countermeasures CNJ-016® and ACAM2000®. These contracts support biodefense and public health preparedness efforts against smallpox and other biological threats, foll…